KIZOO

Kizoo offers their portfolio companies capital and mentoring, and they invest in high growth potential technology and biotechnology companies, especially in the emerging field of rejuvenation biotech. Kizoo supports the creation of startups that turn research on the root causes of aging into therapies and services for humans. Their other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world's cutting-edge medical knowledge, funding research projects on the root causes of aging and hosting the annual Undoing Aging Conference.

Kizoo has made investments in StaffBase, FoxBio, Elevian, shyftplan, Antoxerene, AgeX Therapeutics, CellAge, Lysoclear, MOQO and Ichor Therapeutics.

They exited their investments in AgeX Therapeutics, Prescreen and tamyca.

Kizoo Technology Ventures is a venture capital firm based in KarlsruheKarlsruhe, Germany.

Kizoo Technology Ventures is a venture capital firmventure capital firm based in Karlsruhe, Germany.

Kizoo has made investments in StaffBase, FoxBio, ElevianElevian, shyftplan, Antoxerene, AgeX Therapeutics, CellAge, Lysoclear, MOQO and Ichor Therapeutics.

Kizoo has made investments in StaffBaseStaffBase, FoxBio, Elevian, shyftplan, Antoxerene, AgeX Therapeutics, CellAge, Lysoclear, MOQO and Ichor Therapeutics.

Kizoo has made investments in StaffBase, FoxBio, Elevian, shyftplan, Antoxerene, AgeX TherapeuticsAgeX Therapeutics, CellAge, Lysoclear, MOQO and Ichor Therapeutics.

Kizoo Technology Ventures is a venture capital firm based in Karlsruhe, GermanyGermany.

Kizoo Technology Ventures is a venture capital firm based in Karlsruhe, Germany.

Kizoo offers their portfolio companies capital and mentoring, and they invest in high growth potential technology and biotechnology companies, especially in the emerging field of rejuvenation biotech. Kizoo supports the creation of startups that turn research on the root causes of aging into therapies and services for humans. Their other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world's cutting-edge medical knowledge, funding research projects on the root causes of aging and hosting the annual Undoing Aging Conference.

Kizoo has made investments in StaffBase, FoxBio, Elevian, shyftplan, Antoxerene, AgeX Therapeutics, CellAge, Lysoclear, MOQO and Ichor Therapeutics.

They exited their investments in AgeX Therapeutics, Prescreen and tamyca.